2023 BioTech Life Science 
Digital Health Global
AUGUST 15, 2023
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors. We are delighted to be part of this impactful program.”
Digital Health Global
OCTOBER 11, 2023
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
NOVEMBER 20, 2023
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. Accessed November 2023. Accessed November 2023. Accessed November 2023. Accessed November 2023.
Health Populi
MAY 4, 2023
Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. Reading between the lines of the 2023 IQVIA report tells us as much about public health risks as it does medicines use. is always a detailed, deep, and insightful dive into the state of prescription drugs.
Lloyd Price
SEPTEMBER 2, 2023
Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.
Digital Health Global
APRIL 15, 2024
Today’s announcement comes following the October 2023 acquisition of Healthware Group , an agency and innovation consultancy headquartered in Salerno, Italy. About EVERSANA® EVERSANA® is a leading independent provider of global services to the life sciences industry. They are, however, fully owned and operated by EVERSANA.
Digital Health Global
APRIL 17, 2024
This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digital health, medical devices, life sciences, and tech-enabled care delivery. OpenLoop : An end-to-end telemedicine enablement company surpassed $100 million in annualized revenues in early 2024.
Expert insights. Personalized for you.
88 
Let's personalize your content